|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar
|
|
2
|
Allemani C, Matsuda T, Di Carlo V,
Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ,
Estève J, et al: Global surveillance of trends in cancer survival
2000–14 (CONCORD-3): Analysis of individual records for 37 513 025
patients diagnosed with one of 18 cancers from 322 population-based
registries in 71 countries. Lancet. 391:1023–1075. 2018. View Article : Google Scholar
|
|
3
|
Bray F, Laversanne M, Weiderpass E and
Soerjomataram I: The ever-increasing importance of cancer as a
leading cause of premature death worldwide. Cancer. 127:3029–3030.
2021. View Article : Google Scholar
|
|
4
|
Siegel RL, Miller KD, Wagle NS and Jemal
A: Cancer statistics, 2023. CA Cancer J Clin. 73:17–48. 2023.
View Article : Google Scholar
|
|
5
|
Miao ZF, Chen H, WangZ N, Jia-Fu JI, Liang
H, Xu HM and Wang J: Progress and remaining challenges in
comprehensive gastric cancer treatment. Holistic Integrative
Oncology. 1:2731–4529. 2022. View Article : Google Scholar
|
|
6
|
Lairson LL, Henrissat B, Davies GJ and
Withers SG: Glycosyltransferases: Structures, functions, and
mechanisms. Annu Rev Biochem. 77:521–555. 2008. View Article : Google Scholar
|
|
7
|
Lee TV, Sethi MK, Leonardi J, Rana NA,
Buettner FF, Haltiwanger RS, Bakker H and Jafar-Nejad H: Negative
regulation of notch signaling by xylose. PLoS Genet.
9:e10035472013. View Article : Google Scholar
|
|
8
|
Sethi MK, Buettner FFR, Krylov VB,
Takeuchi H, Nifantiev NE, Haltiwanger RS, Gerardy-Schahn R and
Bakker H: Identification of glycosyltransferase 8 family members as
xylosyltransferases acting on O-glucosylated notch epidermal growth
factor repeats. J Biol Chem. 285:1582–1586. 2010. View Article : Google Scholar
|
|
9
|
Shi Q, Xue C, Zeng Y, Yuan X, Chu Q, Jiang
S, Wang J, Zhang Y, Zhu D and Li L: Notch signaling pathway in
cancer: From mechanistic insights to targeted therapies. Signal
Transduct Target Ther. 27:1282024. View Article : Google Scholar
|
|
10
|
Bakker H and Gerardy-Schahn R: A sweet
development in Notch regulation. J Biol Chem. 292:15974–15975.
2017. View Article : Google Scholar
|
|
11
|
Wharton KA, Johansen KM, Xu T and
Artavanis-Tsakonas S: Nucleotide sequence from the neurogenic locus
notch implies a gene product that shares homology with proteins
containing EGF-like repeats. Cell. 43:567–581. 1985. View Article : Google Scholar
|
|
12
|
Blavier L, Lazaryev A, Shi X-H, Dorey FJ,
Shackleford GM and DeClerck YA: Stromelysin-1 (MMP-3) is a target
and a regulator of Wnt1-induced epithelial-mesenchymal transition
(EMT). Cancer Biol Ther. 10:198–208. 2010. View Article : Google Scholar
|
|
13
|
Chen T, You Y, Jiang H and Wang ZZ:
Epithelial-mesenchymal transition (EMT): A biological process in
the development, stem cell differentiation, and tumorigenesis. J
Cell Physiol. 232:3261–3272. 2017. View Article : Google Scholar
|
|
14
|
Kim DH, Xing T, Yang Z, Dudek R, Lu Q and
Chen YH: Epithelial mesenchymal transition in embryonic
development, tissue repair and cancer: A comprehensive overview. J
Clin Med. 7:12017. View Article : Google Scholar
|
|
15
|
Amack JD: Cellular dynamics of EMT:
Lessons from live in vivo imaging of embryonic development. Cell
Commun Signal. 19:792021. View Article : Google Scholar
|
|
16
|
Urata Y, Saiki W, Tsukamoto Y, Sago H,
Hibi H, Okajima T and Takeuchi H: Xylosyl Extension of O-Glucose
glycans on the extracellular domain of NOTCH1 and NOTCH2 regulates
notch cell surface trafficking. Cells. 9:12202020. View Article : Google Scholar
|
|
17
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC Cancer Staging Manual:
Continuing to build a bridge from a Population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar
|
|
18
|
Weiser TG, Haynes AB, Molina G, Lipsitz
SR, Esquivel MM, Uribe-Leitz T, Fu R, Azad T, Chao TE, Berry WR and
Gawande AA: Size and distribution of the global volume of surgery
in 2012. Bull World Health Organ. 94:201–209F. 2016. View Article : Google Scholar
|
|
19
|
Cisło M, Filip AA, Arnold Offerhaus GJ,
Ciseł B, Rawicz-Pruszyński K, Skierucha M and Polkowski WP:
Distinct molecular subtypes of gastric cancer: From Laurén to
molecular pathology. Oncotarget. 9:19427–19442. 2018. View Article : Google Scholar
|
|
20
|
Hancock CN, Kent L and McClure BA: The
stylar 120 kDa glycoprotein is required for S-specific pollen
rejection in Nicotiana. Plant J. 43:716–723. 2005. View Article : Google Scholar
|
|
21
|
Josè-Estanyol M and Puigdomènech P: Plant
cell wall glycoproteins and their genes. Plant Physiol Biochem.
38:97–108. 2000. View Article : Google Scholar
|
|
22
|
Pearce G, Siems WF, Bhattacharya R, Chen
YC and Ryan CA: Three hydroxyproline-rich glycopeptides derived
from a single petunia polyprotein precursor activate defensin I, a
pathogen defense response gene. J Biol Chem. 282:17777–17784. 2007.
View Article : Google Scholar
|
|
23
|
Tan Z, Lu W, Li X, Yang G, Guo J, Yu H, Li
Z and Guan F: Altered N-Glycan expression profile in
epithelial-to-mesenchymal transition of NMuMG cells revealed by an
integrated strategy using mass spectrometry and glycogene and
lectin microarray analysis. J Proteome Res. 13:2783–2795. 2014.
View Article : Google Scholar
|
|
24
|
Fuster MM and Esko JD: The sweet and sour
of cancer: Glycans as novel therapeutic targets. Nat Rev Cancer.
5:526–542. 2005. View
Article : Google Scholar
|
|
25
|
Munkley J and Elliott DJ: Hallmarks of
glycosylation in cancer. Oncotarget. 7:35478–35489. 2016.
View Article : Google Scholar
|
|
26
|
Pinho SS and Reis CA: Glycosylation in
cancer: Mechanisms and clinical implications. Nat Rev Cancer.
15:540–555. 2015. View
Article : Google Scholar
|
|
27
|
Zhao Y, Hu S, Zhang J, Cai Z, Wang S, Liu
M, Dai J and Gao Y: Glucoside xylosyltransferase 2 as a diagnostic
and prognostic marker in gastric cancer via comprehensive analysis.
Bioengineered. 12:5641–5654. 2021. View Article : Google Scholar
|
|
28
|
Wu Y and Liao Q: MicroRNA-204-5p hampers
the malignant progression of clear cell renal cell carcinoma
through GXYLT2 downregulation. Kidney Blood Press Res. 47:654–663.
2022. View Article : Google Scholar
|
|
29
|
Zhou ZH, Wang QL, Mao LH, Li XQ, Liu P,
Song JW, Liu X, Xu F, Lei J and He S: Chromatin accessibility
changes are associated with enhanced growth and liver metastasis
capacity of Acid-adapted colorectal cancer cells. Cell Cycle.
18:511–522. 2019. View Article : Google Scholar
|
|
30
|
Rana NA, Nita-Lazar A, Takeuchi H, Kakuda
S, Luther KB and Haltiwanger RS: O-glucose trisaccharide is present
at high but variable stoichiometry at multiple sites on mouse
Notch1. J Biol Chem. 286:31623–31637. 2011. View Article : Google Scholar
|
|
31
|
Dongre A and Weinberg RA: New insights
into the mechanisms of Epithelial-mesenchymal transition and
implications for cancer. Nat Rev Mol Cell Biol. 20:69–84. 2019.
View Article : Google Scholar
|
|
32
|
Cui Q, Xing J, Gu Y, Nan X, Ma W, Chen Y
and Zhao H: GXYLT2 accelerates cell growth and migration by
regulating the Notch pathway in human cancer cells. Exp Cell Res.
376:1–10. 2019. View Article : Google Scholar
|
|
33
|
Song YB, Bao WG, Liu DH, Wei LQ, Yang ST,
Miao XJ, Lin CY, Li HJ, Lan D and He HM: Pan-cancer analysis of the
prognostic significance and oncogenic role of GXYLT2. Medicine
(Baltimore). 102:e356642023. View Article : Google Scholar
|
|
34
|
McNamara MG, Jacobs T, Lamarca A, Hubner
RA, Valle JW and Amir E: Impact of high tumor mutational burden in
solid tumors and challenges for biomarker application. Cancer Treat
Rev. 89:1020842020. View Article : Google Scholar
|
|
35
|
Palmeri M, Mehnert J, Silk AW, Jabbour SK,
Ganesan S, Popli P, Riedlinger G, Stephenson R, de Meritens AB,
Leiser A, et al: Real-world application of tumor mutational
burden-high (TMB-high) and microsatellite instability (MSI)
confirms their utility as immunotherapy biomarkers. ESMO Open.
7:1003362022. View Article : Google Scholar
|
|
36
|
Picard E, Verschoor CP, Ma GW and Pawelec
G: Relationships between immune landscapes, genetic subtypes and
responses to immunotherapy in colorectal cancer. Front Immunol.
11:3692020. View Article : Google Scholar
|
|
37
|
World Medical Association: World Medical
Association Declaration of Helsinki: ethical principles for medical
research involving human subjects. JAMA. Nov. 310:2191–2194.
2013.
|
